Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2025 (36)
  • 2024 (38)
  • 2023 (54)
  • 2022 (100)
  • 2021 (79)
  • 2020 (59)
  • 2019 (68)
  • 2018 (46)

Subject

  • Drug Trafficking (272)
  • Guns/Weapons (114)
  • Synthetic drugs (98)
  • OCDETF/Task Force (76)
  • Seizures (Drugs/Property) (75)
  • Fake Pills (56)
  • Task Forces/Task Force Officers (53)
  • Arrests/Convictions - Major (51)
  • Major Law Enforcement Operation (39)
  • Guilty Plea (32)
  • Overdose (30)
  • Gangs (26)
  • Prescription Drugs (24)
  • Money Laundering (18)
  • Outreach/Drug Prevention (18)
  • Diversion Division (12)
  • Pharmaceuticals/Pharmacists/Physicians (12)
  • One Pill Can Kill (9)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • HIDTA (8)
  • Fentanyl Awareness (7)
  • Press Conferences (7)
  • Asset Forfeiture (5)
  • Dark Web- Internet Trafficking (5)
  • Narcoterrorism (5)
  • Congressional Affairs (3)
  • Intelligence Division - Intelligence Products (2)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Cartel (1)
  • Counterfeit Pills (1)
  • Critical Incident (1)
  • Extraditions (1)
  • Fentanyl Free America (1)
  • International/Foreign Operations (1)
  • Take Back Day (1)

Drug Name

  • Fentanyl (2594)
  • Methamphetamine (2143)
  • Cocaine (1929)
  • Heroin (1183)
  • Oxycodone (280)
  • Opioids (120)
  • Ecstasy/MDMA (52)
  • Hydromorphone (40)
  • Benzodiazepines (25)
  • Morphine (21)
  • Amphetamines (19)
  • Steroids (18)
  • Ketamine (15)
  • Marijuana Concentrates (14)
  • Methadone (13)
  • Xylazine (13)
  • K2/Spice (11)
  • LSD (11)
  • Psilocybin (5)
  • Synthetic Bath Salts or Designer Cathinones (5)
  • GHB (2)
  • Barbiturates (1)
  • Peyote & Mescaline (1)
  • Marijuana (Cannabis) (343)
  • Synthetic Opioids (151)

Field Division

  • Washington, DC (97)
  • Atlanta (64)
  • New England (61)
  • St. Louis (34)
  • Houston (29)
  • New York (29)
  • Miami (26)
  • Chicago (22)
  • San Francisco (21)
  • El Paso (18)
  • Seattle (15)
  • Headquarters (12)
  • Rocky Mountain (11)
  • Detroit (8)
  • Dallas (7)
  • Phoenix (7)
  • New Orleans (6)
  • New Jersey (4)
  • Omaha (4)
  • San Diego (3)
  • Los Angeles (2)
  • Louisville (2)
Clear All Results
486 Results - Showing 471 to 480
PRESS RELEASE

Five gang members charged with racketeering and narcotics offenses

NEW YORK - Geoffrey S. Berman, the United States Attorney for the Southern District of New York, Angel M. Melendez, Special Agent-in-Charge of the New York Field Office of U.S. Immigration and Customs Enforcement’s Homeland Security Investigations, James J. Hunt, Special Agent in Charge of the New York Field Division...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
PRESS RELEASE

Record settlement reached in University of Michigan hospital drug diversion civil penalty case

DETROIT - The Drug Enforcement Administration and United States Attorney’s Office for the Eastern District of Michigan today announced that the University of Michigan Health System has agreed to pay the United States $4.3 million as part of a settlement resolving allegations that UMHS violated certain provisions of the Controlled...
PRESS RELEASE

Dayton doctor sentenced for running pill mill

DAYTON, Ohio – David Kirkwood, 62, of Dayton, was sentenced in U.S. District Court today to 70 months in prison and five years of supervised release for running a pill mill in Dayton. In August 2017, Kirkwood and his wife, Beverly Kirkwood, pleaded guilty to health care fraud. David Kirkwood...
PRESS RELEASE

Members of Eastern European organized crime syndicate convicted of racketeering and other violent crimes

BROOKLYN, NY – Earlier today, following more than three weeks of trial, a federal jury in Brooklyn returned guilty verdicts against Leonid “Lenny” Gershman and Aleksey Tsvetkov on charges of racketeering, including predicate acts of illegal gambling, loansharking, extortion, arson and marijuana distribution. The charges arose out of the defendants’...
PRESS RELEASE

DEA investigators seeking answers in small Tennessee town

CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry into irregular patterns of pill purchases from drug distribution companies. DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at...
PRESS RELEASE

Montgomery “pill mill” doctor receives over 12 year sentence for drug distribution, health care fraud, and money laundering offenses

MONTGOMERY, Ala. – Dr. Gilberto Sanchez, 56, of Montgomery, Alabama, was sentenced to serve 12 years and 1 month in prison for prescribing unnecessary controlled substances to his patients, committing health care fraud, and laundering money, announced Drug Enforcement Administration Assistant Special Agent in Charge Bret Hamilton and United States...
PRESS RELEASE

CVS Pharmacy pays one million penalty in settlement with DOJ for violations of the Controlled Substances Act

BIRMINGHAM, Ala. – The Department of Justice has reached an agreement with CVS Pharmacy, Inc. to resolve violations of the federal Controlled Substances Act and its implementing regulations at CVS Pharmacy locations throughout the Northern District of Alabama, announced DEA Special Agent in Charge Stephen G. Azzam and U.S. Attorney...
PRESS RELEASE

Chinese drug traffickers charged in fatal opioid conspiracy

CLEVELAND - While in Cleveland, Ohio, Attorney General Jeff Sessions today announced the unsealing of a 43-count indictment in federal court in Cleveland, which charges two Chinese citizens with operating a conspiracy that manufactured and shipped deadly fentanyl analogues and 250 other drugs to at least 25 countries and 37...
PRESS RELEASE

DEA, DA SINI, U.S. Postal Inspection Service & DA’S East End Drug Task Force announce takedown of alleged Montauk Drug distribution ring

HAUPPAUGE, N.Y. – The Drug Enforcement Administration (DEA), Suffolk County District Attorney Timothy D. Sini, the United States Postal Inspection Service and members of the District Attorney’s Office’s East End Drug Task Force today announced the arrest of 16 individuals in connection with an alleged narcotics ring operating in the...

Pagination

  • First page «
  • Previous
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • Current page 48
  • Page 49
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster